Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4551
CALL
Box
BOX
$4.52B
| $3.01M | ﹤0.01% |
112,200
-146,100
| -57% | -$4.4M |
|
4552
RELX
RELX
$60B
| $3.01M | ﹤0.01% |
92,645
-172,075
| -65% | -$5.16M |
|
|
NUVA
4553
DELISTED
NuVasive, Inc.
NUVA
| $3M | ﹤0.01% |
72,741
-261,130
| -78% | -$11.2M |
|
4554
Ingles Markets
IMKTA
$1.65B
| $3M | ﹤0.01% |
33,871
-3,566
| -10% | -$331K |
|
4555
PUT
Payoneer
PAYO
$2.42B
| $3M | ﹤0.01% |
478,400
+457,000
| +2,136% | +$2.72M |
|
4556
Seres Therapeutics
MCRB
$45.6M
| $3M | ﹤0.01% |
26,485
+26,354
| +20,118% | +$2.85M |
|
4557
CALL
Terex
TEX
$7.76B
| $3M | ﹤0.01% |
62,000
-2,700
| -4% | -$138K |
|
4558
Blackstone
BX
$108B
| $3M | ﹤0.01% |
34,110
-371
| -1% | -$32.8K |
|
|
DOOR
4559
CALL
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $3M | ﹤0.01% |
33,000
+23,900
| +263% | +$2.1M |
|
4560
CALL
iShares Core MSCI EAFE ETF
IEFA
$196B
| $2.99M | ﹤0.01% |
44,800
+14,700
| +49% | +$964K |
|
4561
Mineralys Therapeutics
MLYS
$2.27B
| $2.99M | ﹤0.01% |
+191,048
| New | +$3.22M |
|
4562
Global X Uranium ETF
URA
$6.27B
| $2.99M | ﹤0.01% |
150,091
+9,422
| +7% | +$199K |
|
4563
Arcutis Biotherapeutics
ARQT
$3.29B
| $2.99M | ﹤0.01% |
271,521
+261,888
| +2,719% | +$3.79M |
|
|
FFWM
4564
DELISTED
First Foundation Inc
FFWM
| $2.99M | ﹤0.01% |
400,873
+333,323
| +493% | +$4.45M |
|
4565
Zscaler
ZS
$29.7B
| $2.99M | ﹤0.01% |
25,552
+11,535
| +82% | +$1.38M |
|
4566
CALL
ICICI Bank
IBN
$107B
| $2.98M | ﹤0.01% |
138,300
-35,000
| -20% | -$730K |
|
4567
Immunocore
IMCR
$1.76B
| $2.98M | ﹤0.01% |
60,322
-139,266
| -70% | -$7.83M |
|
4568
PUT
SiriusXM
SIRI
$9.59B
| $2.98M | ﹤0.01% |
75,050
-3,520
| -4% | -$169K |
|
4569
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $2.97M | ﹤0.01% |
39,003
-375,720
| -91% | -$31.2M |
|
|
TPH
4570
DELISTED
Tri Pointe Homes
TPH
| $2.97M | ﹤0.01% |
117,199
+44,073
| +60% | +$998K |
|
4571
Century Communities
CCS
$2.01B
| $2.97M | ﹤0.01% |
46,409
+32,667
| +238% | +$1.95M |
|
4572
iShares MSCI Australia ETF
EWA
$1.45B
| $2.97M | ﹤0.01% |
129,314
+4,500
| +4% | +$105K |
|
|
PRSU
4573
Pursuit Attractions and Hospitality Inc
PRSU
$1.31B
| $2.97M | ﹤0.01% |
142,299
+123,122
| +642% | +$3.07M |
|
4574
CALL
Royalty Pharma
RPRX
$26.1B
| $2.97M | ﹤0.01% |
82,300
+22,100
| +37% | +$819K |
|
|
VRNT
4575
CALL
DELISTED
Verint Systems
VRNT
| $2.96M | ﹤0.01% |
79,600
+41,300
| +108% | +$1.54M |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.